Drug Repurposing: Exploring Potential Anti-Cancer Strategies by Targeting Cancer Signalling Pathways
Natalia Haddad1, Sara Magura Gamaethige1, Nadine Wehida1
1Department of Biomolecular Sciences, Kingston University London, Kingston-upon-Thames KT1 2EE, UK.
Biology
|June 27, 2024
Summary
Drug repurposing offers a faster path to cancer treatment by using approved drugs to target key cancer pathways like WNT and Hippo signaling. This approach bypasses lengthy development, providing new hope for challenging neoplastic diseases.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Drug repurposing leverages existing clinically approved drugs for new therapeutic applications.
- This strategy is gaining traction for treating various neoplastic diseases, including cancers of the colon, brain, and blood.
Purpose of the Study:
- To review and analyze potential anti-cancer compounds for drug repurposing.
- To elucidate the molecular rationale behind repurposing drugs for cancer therapy.
- To explore the potential of repurposed drugs in targeting key oncogenic signaling pathways.
Main Methods:
- Literature review and analysis of existing studies on drug repurposing in oncology.
- Examination of the molecular mechanisms through which repurposed drugs affect cancer-associated genes.
- Focus on the WNT (wingless-related integration type) and Hippo signaling pathways.
Main Results:
- Drug repurposing offers a viable alternative to traditional drug development, utilizing drugs with known efficacy and safety profiles.
- Repurposed drugs can effectively target cancer-associated genes and dysregulated oncogenic signaling pathways.
- Challenges in translation include cancer cell pleiotropy, leading to resistance and incomplete remission.
Conclusions:
- Repurposing clinically approved drugs presents a promising strategy for developing novel cancer therapies.
- Targeting key oncogenic pathways like WNT and Hippo signaling with repurposed drugs holds significant therapeutic potential.
- Further research is needed to overcome resistance mechanisms and improve remission rates in patients.
Keywords:
Wnt signallinganti-canceranti-tumourcancer signallingcancer targetingcancer therapydrug designdrug repurposinghippo signalling pathwaysimmunotherapyMore Related Videos
12:24Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy
Published on: September 29, 2016
7.0K
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10.6K
Related Concept Videos
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K